Skip to main content

Schonfeld Strategic Advisors LLC

Position in GH — Guardant Health, Inc.

CIK 1665241 NEW YORK, NY

Position in GH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$26,927,684
+$20,306,233 QoQ
Shares Held
179,482
+150.4% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#101
of 594 holders
Holding Since
Sep 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GH Over Time

Shares Held

Position Value (USD)

Derivatives in GH

reported options exposure · as of Sep 30, 2022
CallValue
$308,000
CallShares
50,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Schonfeld Strategic Advisors LLC holds $103,808,751 across 23 Diagnostics & Research names. GH ranks #1 (25.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GH
Guardant Health, Inc.
This page
179,482 $26,927,684

All Filings in GH

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $26,927,684 179,482
2026-03-31 $6,621,451 71,684
2025-12-31 $518,973 5,081
2025-09-30 $1,342,195 21,482
2025-06-30 $2,040,800 39,216
2024-12-31 $863,037 28,250
2023-06-30 $1,213,620 33,900
2022-12-31 $3,651,545 134,248
2022-09-30 $5,446,357 101,177
2022-09-30 $308,000 50,000
2022-06-30 $3,420,670 84,796
2022-03-31 $1,656,198 25,003
2021-12-31 $4,402,880 44,020
2021-03-31 $3,458,133 22,654
2020-12-31 $561,272 4,355
2020-09-30 $365,967 3,274